Treatment of refractory anti-melanoma differentiation-associated gene 5 anbibody-positive dermatomyositis complicated by rapidly progressing interstitial pulmonary disease: Two case reports

doi:10.12998/wjcc.v11.i22.5351

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 22

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1943)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series.

Item

Count

PDF

WORD

HTML

848

Figures (1-3)

175

Sum=1075

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

122

Download

282

Sum=404

Publishing Process of This Article

Item

Count

Browse

Download

288

Sum=375

Aug 6, 2023 (publication date) through May 19, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Aug 6, 2023; 11(22): 5351-5357
Published online Aug 6, 2023. doi: 10.12998/wjcc.v11.i22.5351

Full Size Figure Download Figure

Figure 3 Regimen adopted for the treatment of Case 2. IVIG: Intravenous gamma globulin; Mpsl: Methylprednisolone; Tac: Tacrolimus; Oxy: Oxygenation support; SMZco: Sulfamethoxazole complex.

Citation: Wang QH, Chen LH. Treatment of refractory anti-melanoma differentiation-associated gene 5 anbibody-positive dermatomyositis complicated by rapidly progressing interstitial pulmonary disease: Two case reports. World J Clin Cases 2023; 11(22): 5351-5357
URL: https://www.wjgnet.com/2307-8960/full/v11/i22/5351.htm
DOI: https://dx.doi.org/10.12998/wjcc.v11.i22.5351